Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Roumeliotis

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Vascular Pharmacology|April 3, 2020
Cardiovascular Benefits of Extended-Time Nocturnal HemodialysisAthanasios Roumeliotis, Stefanos Roumeliotis, Christopher Chan, et al.
Current Vascular Pharmacology|March 19, 2020
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?Stefanos Roumeliotis, Athanasios Roumeliotis, Xenia Gorny, et al.
Nutrients|August 25, 2019
Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A ReviewStefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
Journal of Cutaneous Medicine and Surgery|April 12, 2011
Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factorsDespoina Kakagia, Pelagia Kriki, Elias Thodis, et al.
Advances in Clinical Chemistry|June 23, 2020
Biomarkers of vascular calcification in serumStefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
International Urology and Nephrology|September 19, 2013
Vascular access for hemodialysis: postoperative evaluation and function monitoringKonstantinos Leivaditis, Stelios Panagoutsos, Athanasios Roumeliotis, et al.
Current Vascular Pharmacology|March 21, 2020
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?Stefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
International Urology and Nephrology|January 2, 2023
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory propertiesDainora Cepaityte, Konstantinos Leivaditis, Garyfallia Varouktsi, et al.
International Urology and Nephrology|October 14, 2020
APD or CAPD: one glove does not fit allAthanasios Roumeliotis, Stefanos Roumeliotis, Konstantinos Leivaditis, et al.
Biomolecules|January 28, 2026
Association of Oxidative Stress Markers with Cardio-Kidney-Metabolic Parameters and Cardiovascular Disease in Patients with Type 2 Diabetes MellitusStefanos Roumeliotis, Ioannis E Neofytou, Athanasios Roumeliotis, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Vascular Pharmacology|April 3, 2020
Cardiovascular Benefits of Extended-Time Nocturnal HemodialysisAthanasios Roumeliotis, Stefanos Roumeliotis, Christopher Chan, et al.
Current Vascular Pharmacology|March 19, 2020
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?Stefanos Roumeliotis, Athanasios Roumeliotis, Xenia Gorny, et al.
Nutrients|August 25, 2019
Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A ReviewStefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
Journal of Cutaneous Medicine and Surgery|April 12, 2011
Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factorsDespoina Kakagia, Pelagia Kriki, Elias Thodis, et al.
Advances in Clinical Chemistry|June 23, 2020
Biomarkers of vascular calcification in serumStefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
International Urology and Nephrology|September 19, 2013
Vascular access for hemodialysis: postoperative evaluation and function monitoringKonstantinos Leivaditis, Stelios Panagoutsos, Athanasios Roumeliotis, et al.
Current Vascular Pharmacology|March 21, 2020
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?Stefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, et al.
International Urology and Nephrology|January 2, 2023
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory propertiesDainora Cepaityte, Konstantinos Leivaditis, Garyfallia Varouktsi, et al.
International Urology and Nephrology|October 14, 2020
APD or CAPD: one glove does not fit allAthanasios Roumeliotis, Stefanos Roumeliotis, Konstantinos Leivaditis, et al.
Biomolecules|January 28, 2026
Association of Oxidative Stress Markers with Cardio-Kidney-Metabolic Parameters and Cardiovascular Disease in Patients with Type 2 Diabetes MellitusStefanos Roumeliotis, Ioannis E Neofytou, Athanasios Roumeliotis, et al.
Pageof 4